These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9327986)
1. Central and peripheral norepinephrine kinetics in heart failure, coronary artery disease, and hypertension. Esler M; Lambert G; Jennings G; Turner A; Kaye D Adv Pharmacol; 1998; 42():650-3. PubMed ID: 9327986 [No Abstract] [Full Text] [Related]
2. Central nervous system norepinephrine turnover in essential hypertension. Lambert GW; Ferrier C; Kaye DM; Jennings GL; Kalff V; Kelly MJ; Cox HS; Turner AG; Esler MD Ann N Y Acad Sci; 1995 Jul; 763():679-94. PubMed ID: 7677388 [No Abstract] [Full Text] [Related]
3. Increased norepinephrine spillover into the jugular veins in essential hypertension. Ferrier C; Esler MD; Eisenhofer G; Wallin BG; Horne M; Cox HS; Lambert G; Jennings GL Hypertension; 1992 Jan; 19(1):62-9. PubMed ID: 1730441 [TBL] [Abstract][Full Text] [Related]
4. Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension. Esler M; Lambert G; Vaz M; Thompson J; Kaye D; Kalff V; Kelly M; Turner A; Jennings G Clin Exp Hypertens; 1997; 19(5-6):577-90. PubMed ID: 9247740 [TBL] [Abstract][Full Text] [Related]
5. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. Lambert GW; Kaye DM; Lefkovits J; Jennings GL; Turner AG; Cox HS; Esler MD Circulation; 1995 Oct; 92(7):1813-8. PubMed ID: 7545554 [TBL] [Abstract][Full Text] [Related]
6. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Esler M; Jennings G; Korner P; Willett I; Dudley F; Hasking G; Anderson W; Lambert G Hypertension; 1988 Jan; 11(1):3-20. PubMed ID: 2828236 [No Abstract] [Full Text] [Related]
7. Sympathetically mediated hypertension in autonomic failure. Shannon JR; Jordan J; Diedrich A; Pohar B; Black BK; Robertson D; Biaggioni I Circulation; 2000 Jun; 101(23):2710-5. PubMed ID: 10851208 [TBL] [Abstract][Full Text] [Related]
8. Differences in norepinephrine levels in different vascular beds in congestive heart failure. Eichhorn EJ; Hatfield BA; Marcoux L Am J Cardiol; 1993 Feb; 71(5):442-6. PubMed ID: 8430636 [No Abstract] [Full Text] [Related]
9. Relationship between sympathetic nerve traffic and plasma concentrations of noradrenaline in man. Wallin BG Pharmacol Toxicol; 1988; 63 Suppl 1():9-11. PubMed ID: 3200794 [No Abstract] [Full Text] [Related]
10. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure. Esler M; Kaye D J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571 [TBL] [Abstract][Full Text] [Related]
11. [The sympathetic nervous system and hypertension--metabolites of norepinephrine, 3-methoxy-4-hydroxyphenylglycol sulfate and normetanephrine]. Xie SW Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Sep; 12(3):180-3, 238. PubMed ID: 6532759 [No Abstract] [Full Text] [Related]
12. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. Kaye DM; Lambert GW; Lefkovits J; Morris M; Jennings G; Esler MD J Am Coll Cardiol; 1994 Mar; 23(3):570-8. PubMed ID: 8113536 [TBL] [Abstract][Full Text] [Related]